Lansoprazole Capsule, Delayed Release
Product Images NDC 68071-3687

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68071-3687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3687 3)

Pdp (68071 3687 3)
Label for Lansoprazole 15 mg delayed-release capsules by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 30 capsules and includes product number R1790030. Manufacturer details show Dr. Reddy's Laboratories Limited, India. The label instructs to see the manufacturer's label for a full ingredient list and includes warnings to keep out of reach of children and store at controlled temperature 68-77°F.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph depicting mean severity of day heartburn over time from the start of treatment, comparing placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily. Severity is rated from 0 (none) to 3 (severe), with data shown for up to 60 days.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line chart showing the mean severity of night heartburn over days from the start of treatment for three groups: placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily. The y-axis indicates severity levels from 0 (none) to 3 (severe), and the x-axis represents days up to 60. Lansoprazole groups show a decrease in severity compared to placebo over time.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of lansoprazole, showing the molecular arrangement including the benzimidazole ring, sulfinyl linkage, and substituted pyridine ring with trifluoromethoxy group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.